CARsgen Therapeutics Holdings Limited
CRTHF
$0.76
$0.01351.81%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 24.52% | 9.05% | -4.81% | 12.41% | 27.32% |
| Total Depreciation and Amortization | -13.40% | -44.23% | -59.13% | -57.10% | -55.79% |
| Total Amortization of Deferred Charges | 14.70% | 14.70% | 14.70% | 46.52% | 108.78% |
| Total Other Non-Cash Items | 164.50% | 400.68% | 7,748.31% | -47.86% | -139.54% |
| Change in Net Operating Assets | -74.69% | -74.69% | -74.69% | 3.93% | 368.72% |
| Cash from Operations | 38.46% | 26.18% | 10.76% | -3.69% | -15.57% |
| Capital Expenditure | -1,550.71% | -172.27% | -46.76% | 48.64% | 95.68% |
| Sale of Property, Plant, and Equipment | -475.71% | -1,085.29% | -13,533.33% | -523.21% | -163.64% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -95.24% | -90.18% | -13.39% | -74.88% | -76.48% |
| Cash from Investing | -98.29% | -95.75% | -40.79% | -75.29% | -76.29% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -212.07% | -136.57% | -90.49% | 77.17% | 93.91% |
| Issuance of Common Stock | 1,869.80% | 876.72% | 549.35% | 158.86% | -79.85% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -245.95% | -164.54% | 557.05% | 412.78% | 340.74% |
| Cash from Financing | -453.96% | -42.93% | 182.23% | 110.91% | 104.15% |
| Foreign Exchange rate Adjustments | -117.68% | -106.11% | -56.32% | 448.36% | 280.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,127.95% | -62.54% | 16.13% | -162.95% | -102.85% |